329 related articles for article (PubMed ID: 11123381)
21. Significance of glycine 478 in the metabolism of N-benzyl-1-aminobenzotriazole to reactive intermediates by cytochrome P450 2B1.
Kent UM; Hanna IH; Szklarz GD; Vaz AD; Halpert JR; Bend JR; Hollenberg PF
Biochemistry; 1997 Sep; 36(39):11707-16. PubMed ID: 9305960
[TBL] [Abstract][Full Text] [Related]
22. Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic activity of cytochrome P450 2B1.
Roberts ES; Lin Hl; Crowley JR; Vuletich JL; Osawa Y; Hollenberg PF
Chem Res Toxicol; 1998 Sep; 11(9):1067-74. PubMed ID: 9760281
[TBL] [Abstract][Full Text] [Related]
23. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by n-propylxanthate.
Kent UM; Yanev S; Hollenberg PF
Chem Res Toxicol; 1999 Apr; 12(4):317-22. PubMed ID: 10207119
[TBL] [Abstract][Full Text] [Related]
24. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
Amato G; Longo V; Mazzaccaro A; Gervasi PG
Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic studies of cytochrome P450 2B1 inactivation by xanthates.
Yanev SG; Kent UM; Roberts ES; Ballou DP; Hollenberg PF
Arch Biochem Biophys; 2000 Jun; 378(1):157-66. PubMed ID: 10871056
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of naturally occurring isothiocyanates on the activities of cytochrome P450 2E1 and the mutant P450 2E1 T303A.
Moreno RL; Goosen T; Kent UM; Chung FL; Hollenberg PF
Arch Biochem Biophys; 2001 Jul; 391(1):99-110. PubMed ID: 11414690
[TBL] [Abstract][Full Text] [Related]
27. Redox cycling in the metabolism of the environmental pollutant and suspected human carcinogen o-anisidine by rat and rabbit hepatic microsomes.
Naiman K; Dracínská H; Martínková M; Sulc M; Dracínský M; Kejíková L; Hodek P; Hudecek J; Liberda J; Schmeiser HH; Frei E; Stiborová M
Chem Res Toxicol; 2008 Aug; 21(8):1610-21. PubMed ID: 18624415
[TBL] [Abstract][Full Text] [Related]
28. Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450.
Shou M; Krausz KW; Gonzalez FJ; Gelboin HV
Arch Biochem Biophys; 1996 Apr; 328(1):201-7. PubMed ID: 8638931
[TBL] [Abstract][Full Text] [Related]
29. Mechanism-based inactivation of rat liver cytochrome P-450 2B1 by 2-methoxy-5-nitrobenzyl bromide.
Armstrong AP; Hollenberg PF
Drug Metab Dispos; 1999 Jun; 27(6):741-5. PubMed ID: 10348806
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of cytochromes P450 2B protects against cocaine-mediated toxicity in rat liver slices.
Poet TS; Brendel K; Halpert JR
Toxicol Appl Pharmacol; 1994 May; 126(1):26-32. PubMed ID: 8184429
[TBL] [Abstract][Full Text] [Related]
31. cDNA-expressed human cytochrome P450 isozymes. Inactivation by porphyrinogenic xenobiotics.
McNamee JP; Jurima-Romet M; Kobus SM; Marks GS
Drug Metab Dispos; 1997 Apr; 25(4):437-41. PubMed ID: 9107543
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
[TBL] [Abstract][Full Text] [Related]
33. Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450.
Miller KK; Cai J; Ripp SL; Pierce WM; Rushmore TH; Prough RA
Drug Metab Dispos; 2004 Mar; 32(3):305-13. PubMed ID: 14977864
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo.
Thapliyal R; Maru GB
Food Chem Toxicol; 2001 Jun; 39(6):541-7. PubMed ID: 11346483
[TBL] [Abstract][Full Text] [Related]
35. The functional role of threonine-205 in the mechanism-based inactivation of P450 2B1 by two ethynyl substrates: the importance of the F helix in catalysis.
Lin HL; Kent UM; Zhang H; Waskell L; Hollenberg PF
J Pharmacol Exp Ther; 2004 Dec; 311(3):855-63. PubMed ID: 15302894
[TBL] [Abstract][Full Text] [Related]
36. Identification of amino acid residues involved in the inactivation of cytochrome P450 2B1 by two acetylenic compounds: the role of three residues in nonsubstrate recognition Sites.
Von Weymarn LB; Sridar C; Hollenberg PF
J Pharmacol Exp Ther; 2004 Oct; 311(1):71-9. PubMed ID: 15178696
[TBL] [Abstract][Full Text] [Related]
37. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
38. Short-term inhibitory effects of nitric oxide on cytochrome P450-mediated drug metabolism: time dependency and reversibility profiles in isolated perfused rat livers.
Vuppugalla R; Mehvar R
Drug Metab Dispos; 2004 Dec; 32(12):1446-54. PubMed ID: 15383494
[TBL] [Abstract][Full Text] [Related]
39. Time course for the modulation of hepatic cytochrome P450 after administration of ethylbenzene and its correlation with toluene metabolism.
Yuan W; Sequeira DJ; Cawley GF; Eyer CS; Backes WL
Arch Biochem Biophys; 1997 Mar; 339(1):55-63. PubMed ID: 9056233
[TBL] [Abstract][Full Text] [Related]
40. Enzymes involved in the metabolism of the carcinogen 2-nitroanisole: evidence for its oxidative detoxication by human cytochromes P450.
Miksanová M; Sulc M; Rýdlová H; Schmeiser HH; Frei E; Stiborová M
Chem Res Toxicol; 2004 May; 17(5):663-71. PubMed ID: 15144223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
